top of page

Search

JY BioMed Unveils International Development Framework for GDT Cell Therapy in Glioblastoma

Aug 7

3 min read

Recent Posts

Dr. Ethan Shen and Dr. Benjamin Zhang of JY BioMed at the World Congress of Pharmacy WCP 2026 in Melbourne

Preclinical Breakthrough of GDT Cell Therapy in Brain Cancer Presented at the WCP 2026

JY BioMed's HCAb-ADC Technology Earns National Innovation Award, Advancing International Licensing

JY BioMed's HCAb-ADC Technology Earns National Innovation Award, Advancing International Licensing

JY BioMed Secures Dual FDA Recognition, Establishing Early Leadership in the Exosome Space

JY BioMed Secures Dual FDA Recognition, Establishing Early Leadership in the Exosome Space

bottom of page